Quarterly report · Q1
3583.TEDINET S100OWKG
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥154m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥148m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥178m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥150m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥150m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥161m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥537m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥104m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥161m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥104m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.0bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.5bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.9bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥58.32 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.04 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.48 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥221,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥3m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥353m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥352m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥25m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥981m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥981m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥205m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥230m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥227m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥822,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥822,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥5m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥329m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥328m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥36m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥973m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥973m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥220m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 373
| Item | Context | Value | Unit |
|---|---|---|---|
| Other noe | Prior1YTDDuration | 54000 | JPY |
| Other noe | CurrentYTDDuration | 1554000 | JPY |
| Non operating expenses | Prior1YTDDuration | 3825000 | JPY |
| Non operating expenses | CurrentYTDDuration | 4858000 | JPY |
| Ordinary income | Prior1YTDDuration | 149722000 | JPY |
| Ordinary income | CurrentYTDDuration | 177622000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | － | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 55871000 | JPY |
| Extraordinary income | Prior1YTDDuration | － | JPY |
| Extraordinary income | CurrentYTDDuration | 55871000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 6000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 42000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | － | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 2826000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 6000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 2869000 | JPY |
| Income before income taxes | Prior1YTDDuration | 149715000 | JPY |
| Income before income taxes | CurrentYTDDuration | 230624000 | JPY |
| Income taxes current | Prior1YTDDuration | 32957000 | JPY |
| Income taxes current | CurrentYTDDuration | 2566000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 13179000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 66601000 | JPY |
| Income taxes | Prior1YTDDuration | 46137000 | JPY |
| Income taxes | CurrentYTDDuration | 69168000 | JPY |
| Profit loss | Prior1YTDDuration | 103578000 | JPY |
| Profit loss | CurrentYTDDuration | 161456000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 103578000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 161456000 | JPY |
| Profit loss | Prior1YTDDuration | 103578000 | JPY |
| Profit loss | CurrentYTDDuration | 161456000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 366000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 3527000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 2781000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 21399000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 3147000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 24926000 | JPY |
| Comprehensive income | Prior1YTDDuration | 106726000 | JPY |
| Comprehensive income | CurrentYTDDuration | 186382000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 106726000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 186382000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember | 973205000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember | 327947000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 1301153000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 822000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1301975000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember | 891000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 891000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 891000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |